Featuring perspectives from Dr Daniel Pollyea, including the following topics:
- Introduction (0:00)
- Acute Myeloid Leukemia (AML), 2014 to 2022 (3:35)
- Defining AML versus Myelodysplastic Syndromes (6:06)
- Case: A man in his early 80s presenting with cytopenias and AML (8:56)
- Oral Decitabine/Cedazuridine (18:15)
- Management of Cytopenias with HMA (Hypomethylating Agent)/Venetoclax: Drug-Drug Interactions (26:43)
- HMA/Venetoclax for Younger Patients (39:56)
- Translational Biology of AML: New Agents and Treatment Strategies (44:08)
- Case: A man in his mid 70s with p53-mutated AML and complex karyotype (47:48)
- Anti-CD47 Antibody Magrolimab (51:08)
- Case: A woman in her early 60s with MLL-rearranged AML after receiving 7 + 3, FLAG-IDA and azacitidine/venetoclax (54:22)
CME information and select publications
Research To Practice | Oncology Videos